Jatenzo Cost in Alabama 2026: Cash Price, Insurance, Medicaid, and Compounded Alternatives

At a glance
- Manufacturer list price / ~$900/month (2026 Tolmar WAC)
- Alabama Medicaid coverage / Not covered
- Commercial insurance / Varies by plan; prior authorization typically required
- Compounded oral TU via 503A / Legal in Alabama; price varies, often $0-$150/month
- Tolmar savings card / Eligible commercially insured patients may pay as low as $0/month copay
- Dosing / 158-237 mg orally twice daily with a meal containing at least 19 g fat
- FDA approval year / 2019 (NDA 210650)
- Prescribable via telehealth in Alabama / Yes
What Is the Cash Price of Jatenzo in Alabama in 2026?
The retail cash price for a 30-day supply of Jatenzo at Alabama pharmacies runs approximately $900 per month in 2026, consistent with Tolmar Pharmaceuticals' wholesale acquisition cost (WAC) since the drug's launch. Prices at individual pharmacies vary by a few percent, but no major generic version exists, so there is no deep discount tier to access.
Jatenzo received FDA approval in March 2019 under NDA 210650 as the first oral testosterone therapy approved in the United States in decades. The FDA label specifies starting doses of 158 mg twice daily with food, with titration to 237 mg twice daily based on serum testosterone levels drawn 3 to 5 hours post-dose [1]. Because the drug requires fat to be absorbed via intestinal lymphatics, patients must consume at least 19 grams of dietary fat with each dose. Missing that requirement substantially reduces bioavailability and makes monitoring results unreliable [2].
The $900 figure reflects the brand-only market. Testosterone undecanoate (TU) is an older molecule, but Jatenzo's proprietary lipid-based oral formulation is patent-protected, keeping the price high for the branded product specifically. A 90-day supply, where available, does not reliably reduce the per-month cost without an active manufacturer offer or a specific pharmacy benefit [3].
Alabama residents paying cash should check GoodRx, RxSaver, and the Tolmar patient savings program before filling at retail. The Tolmar savings card (discussed below) is the most direct route to cost reduction for commercially insured patients [4].
Does Alabama Medicaid Cover Jatenzo?
Alabama Medicaid does not cover Jatenzo as of 2026. The Alabama Medicaid Agency's Preferred Drug List (PDL) does not include oral testosterone undecanoate in its covered formulary for male hypogonadism. This means Medicaid beneficiaries cannot obtain Jatenzo through the state program even with a prior authorization request under standard pathways.
The Endocrine Society's 2018 clinical practice guideline on testosterone therapy recommends testosterone replacement for men with classic hypogonadism confirmed by two low morning total testosterone measurements, defined as below 300 ng/dL in most laboratory reference ranges [5]. Alabama Medicaid does cover other testosterone formulations. These include testosterone cypionate injection and certain topical gels, which carry lower acquisition costs and appear on the PDL as preferred agents. Patients on Medicaid who need testosterone therapy should discuss these alternatives with their prescriber. Switching from Jatenzo to an injectable or gel that Medicaid does cover is usually the most straightforward path for this population.
Exceptions for non-covered drugs through Alabama Medicaid require a formal prior authorization and a demonstration of medical necessity superior to covered alternatives. Given that injectable testosterone cypionate is inexpensive and clinically effective, approvals for Jatenzo through this exception pathway are uncommon [6].
Which Commercial Insurance Plans Cover Jatenzo in Alabama?
Coverage for Jatenzo through commercial insurance in Alabama is possible but inconsistent across plans. Most major carriers, including BlueCross BlueShield of Alabama, United Healthcare, Aetna, and Cigna, place Jatenzo on a non-preferred specialty tier or exclude it entirely from standard formularies.
When a plan does include Jatenzo, prior authorization is almost always required. Typical PA criteria include [7]:
- Confirmed diagnosis of male hypogonadism (ICD-10 E29.1)
- Two morning serum testosterone measurements below the lab's lower reference limit, generally below 300 ng/dL
- Documentation that the patient is an appropriate candidate for oral rather than injectable or topical testosterone
- Prescriber attestation that the patient can comply with twice-daily dosing with fat-containing meals
Step-therapy requirements are also common. Some plans require a trial of a less expensive testosterone formulation (usually generic testosterone cypionate injection) before approving Jatenzo. Patients who are needle-averse, have a documented allergy to injectable vehicles, or have a clinical reason to avoid injection sites may have a stronger case for bypassing step therapy [8].
The best approach before filling is to call the member services number on your insurance card and ask specifically about the formulary tier for Jatenzo (NDC prefix 70714) and whether a PA form is available for download. Your HealthRX-affiliated prescriber can initiate the PA electronically in most cases.
How Does the Tolmar Savings Card Work in Alabama?
The Tolmar Jatenzo savings card can reduce out-of-pocket cost to as low as $0 per month for eligible commercially insured patients in Alabama. Patients with Medicare, Medicaid, or any other federal or state government-funded insurance are not eligible, consistent with federal anti-kickback regulations.
Enrollment is available at the Tolmar patient support portal. Once enrolled, the card works like a secondary insurance at the pharmacy counter and covers the gap between what your commercial plan pays and the retail price, up to a maximum program benefit per fill. The program benefit cap resets annually. Patients should verify the current cap directly with Tolmar because it changes with program updates [9].
Key practical points for Alabama residents:
- The savings card is accepted at most major retail chains in Alabama, including CVS, Walgreens, Walmart Pharmacy, and Publix Pharmacy.
- It cannot be combined with government insurance. Using it when you are enrolled in a government plan is a federal compliance issue.
- If your commercial plan denies Jatenzo entirely, the savings card cannot make the drug free. It reduces cost-sharing on covered fills, not on cash-pay fills (though Tolmar has run separate cash-pay patient assistance programs at various times, so contacting Tolmar directly is worth doing if you lack insurance).
- The card covers the branded product only. It does not apply to compounded testosterone undecanoate [10].
Is Compounded Oral Testosterone Undecanoate Legal in Alabama?
Compounded oral testosterone undecanoate is legally available in Alabama through licensed 503A compounding pharmacies. 503A refers to Section 503A of the Federal Food, Drug, and Cosmetic Act, which governs traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription from a licensed prescriber [11].
Testosterone undecanoate is not on the FDA's list of bulk drug substances that may not be compounded under 503A, so Alabama-licensed compounding pharmacies may prepare it. The Alabama State Board of Pharmacy oversees these pharmacies at the state level, and federal USP standards (USP 795 for non-sterile compounding) apply to oral capsule preparations [12].
The clinical data on Jatenzo itself provides context for what the compounded form is intended to replicate. Swerdloff et al. published the key phase 3 trial in the Journal of Clinical Endocrinology and Metabolism. In that study (N=166 evaluable patients), 87% of subjects achieved average total testosterone concentrations in the normal range (300 to 1 to 000 ng/dL) with Jatenzo over 52 weeks [13]. The FDA-approved product uses a specific lipid vehicle to support lymphatic absorption. Compounded formulations attempt to replicate this mechanism but are not required to demonstrate bioequivalence to the branded product, so clinical outcomes from the branded trial cannot be assumed to transfer directly to every compounded version [14].
Pricing for compounded oral TU through Alabama 503A pharmacies varies considerably. Some compounding pharmacies charge $50 to $150 per month. A subset of telehealth platforms that partner with in-network compounding pharmacies offer it at lower still rates, and in some membership-model practices the effective cost approaches $0 per month after a platform fee. Patients should confirm that their prescriber has an active Alabama medical license and that the dispensing pharmacy holds a current Alabama Board of Pharmacy permit [15].
How Does Jatenzo Compare to Other Testosterone Options on Cost?
Understanding where Jatenzo sits relative to other testosterone therapies helps Alabama patients make an informed choice with their prescriber.
Generic testosterone cypionate injection (200 mg/mL, 10 mL vial) costs approximately $30 to $60 per vial at most Alabama pharmacies, with each vial lasting 5 to 10 weeks depending on dose. That translates to roughly $15 to $50 per month for the medication itself, plus the cost of syringes and any clinical administration fees [16]. The American Urological Association and Endocrine Society guidelines both recognize injectable testosterone as a first-line option with a long safety and efficacy record [5].
Testosterone topical gels (AndroGel 1.62%, Testim, and their generics) range from $30 to $150 per month at Alabama pharmacies depending on generic availability and dose. Transfer risk to partners and children is a documented concern with topicals, and patients must follow strict hand-washing and covering protocols [17].
Testosterone pellets implanted subcutaneously every 3 to 6 months cost $300 to $600 per insertion at Alabama urology and men's health clinics, roughly $75 to $200 per month amortized. The procedure requires a minor in-office surgical visit [18].
Jatenzo's specific advantages over these alternatives are the avoidance of injections or topicals, discreet twice-daily oral dosing, and no skin-transfer risk. For patients who genuinely prefer oral administration and can comply with twice-daily food timing requirements, those advantages may justify the higher cost through the savings card or compounded route [19].
Can I Get Jatenzo via Telehealth in Alabama?
Telehealth prescribing of Jatenzo in Alabama is permitted. Alabama participated in the expansion of telehealth prescribing that followed the 2020 federal public health emergency. For controlled substances, including testosterone (Schedule III), the Ryan Haight Online Pharmacy Consumer Protection Act normally requires at least one in-person evaluation before remote prescribing. The DEA's 2023 proposed telemedicine rules, and subsequent extensions of pandemic-era flexibilities, created pathways under which established telehealth providers may prescribe Schedule III substances with an audio-video visit in states that permit it [20].
Alabama law does not impose a blanket prohibition on telehealth testosterone prescribing beyond federal requirements. The Alabama Board of Medical Examiners requires that telehealth prescribers establish a valid prescriber-patient relationship, which for testosterone means a documented clinical history, symptom review, and review of qualifying laboratory values (total testosterone, LH, FSH, hematocrit, and PSA at minimum) before prescribing [21].
HealthRX-affiliated providers can initiate a Jatenzo evaluation for Alabama residents through a synchronous audio-video visit. Labs can be ordered to any LabCorp or Quest location in Alabama. If the clinical picture supports hypogonadism, a prescription can be sent electronically to a pharmacy or compounding partner in most cases within 24 to 48 hours of confirmed lab results [22].
The HealthRX Alabama TRT access framework ranks options in this sequence for most patients: (1) confirm diagnosis with two morning total testosterone draws below 300 ng/dL, (2) determine insurance type and check formulary for Jatenzo and generic testosterone cypionate, (3) if commercially insured with Jatenzo covered, apply Tolmar savings card, (4) if Medicaid or uninsured, evaluate compounded oral TU or generic injectable with cost comparison, (5) reassess total testosterone 6 to 8 weeks after starting any new formulation.
Monitoring Requirements That Affect Total Cost in Alabama
The cost of Jatenzo is not just the monthly pharmacy fill. Ongoing laboratory monitoring adds to the real-world expense and is non-negotiable from a safety standpoint.
The FDA-approved Jatenzo label requires serum total testosterone drawn 3 to 5 hours after the morning dose at steady state (after at least a week of consistent dosing). Dose titration targets a Cavg in the normal range of 300 to 1 to 000 ng/dL [1]. A venous draw at LabCorp or Quest in Alabama without insurance runs approximately $30 to $60 for a total testosterone test.
The Endocrine Society guideline recommends monitoring hematocrit at baseline, 3 to 6 months, then annually, because supraphysiologic testosterone elevates red blood cell production. Hematocrit above 54% warrants dose reduction or temporary discontinuation [5]. Jatenzo's label specifically notes a boxed warning about blood pressure elevation: in the key trial, mean systolic blood pressure increased by 3.5 mmHg at 52 weeks versus baseline, and 21% of patients required new or intensified antihypertensive treatment [1]. Blood pressure monitoring at each clinical visit is required.
PSA screening per AUA guidelines is recommended at baseline and annually for men over 40, or sooner if PSA rises more than 1.4 ng/mL above baseline within 12 months [23]. Adding these monitoring visits and labs to the $900/month medication cost means the real annual expenditure for uninsured Alabama patients on branded Jatenzo approaches $11,000 to $12,000 per year [24].
What Is the Cheapest Way to Get Testosterone Therapy in Alabama?
For Alabama patients whose primary goal is the lowest possible out-of-pocket cost while treating confirmed hypogonadism, generic testosterone cypionate injection remains the most affordable option at approximately $15 to $50 per month. Alabama Medicaid covers it on the PDL [6].
For patients who need or strongly prefer oral testosterone specifically, compounded oral testosterone undecanoate through a licensed Alabama 503A pharmacy is the lowest-cost oral route, often $50 to $150 per month or less through certain telehealth platforms. The compounded product avoids the branded $900 price point entirely [15].
Commercially insured patients with Jatenzo on formulary who enroll in the Tolmar savings card program can access branded Jatenzo at $0 to minimal copay per month, making it effectively as inexpensive as any other option [9].
Patients who are uninsured, do not qualify for the savings card, and do not want injections should contact Tolmar's patient assistance program directly. Tolmar offers an income-based free drug program for patients who meet financial eligibility criteria, and the income thresholds have historically been set at or below 400% of the federal poverty level [4].
Frequently asked questions
›How much does Jatenzo cost in Alabama?
›Does Alabama Medicaid cover Jatenzo?
›Is compounded oral testosterone undecanoate legal in Alabama?
›Can I get Jatenzo via telehealth in Alabama?
›Which insurance plans cover Jatenzo in Alabama?
›What's the cheapest way to get Jatenzo in Alabama?
›Are there Alabama Jatenzo discount programs?
›How does the Tolmar savings card work in Alabama?
References
- Jatenzo (testosterone undecanoate) prescribing information. Tolmar Pharmaceuticals; 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210650s000lbl.pdf
- Yin OQ, Tomlinson B, Chow MS. Absorption and disposition of testosterone undecanoate after single-dose oral administration in healthy male volunteers. J Clin Pharmacol. 2003. https://pubmed.ncbi.nlm.nih.gov/12690546/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Tolmar Pharmaceuticals patient support. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210650s000lbl.pdf
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Alabama Medicaid Agency Preferred Drug List. https://www.medicaid.gov/state-overviews/stateprofile.html?state=al
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- FDA Drug Approval Information for Jatenzo NDA 210650. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210650
- Pastuszak AW, Hu Y, Frysh S, et al. Testosterone replacement therapy with oral testosterone undecanoate and systolic blood pressure: a post-hoc analysis. J Urol. 2020. https://pubmed.ncbi.nlm.nih.gov/31773132/
- US Food and Drug Administration. Compounding Laws and Policies: Section 503A. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- US Pharmacopeial Convention. USP General Chapter 795 Pharmaceutical Compounding - Nonsterile Preparations. https://www.ncbi.nlm.nih.gov/books/NBK585040/
- Swerdloff RS, Wang C, White WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515-2531. https://pubmed.ncbi.nlm.nih.gov/31773132/
- Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. Testosterone supplementation in males with male-factor infertility. Fertil Steril. 2015. https://pubmed.ncbi.nlm.nih.gov/25316442/
- Alabama State Board of Pharmacy. Compounding Rules. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Testosterone cypionate injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s031lbl.pdf
- AndroGel (testosterone gel) prescribing information. AbbVie. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s039lbl.pdf
- Bhattacharya RK, Bhattacharya SB. Subcutaneous testosterone pellets for hypogonadism: a review. J Mens Health. 2012. https://pubmed.ncbi.nlm.nih.gov/22462910/
- Morgentaler A, Zitzmann M, Traish AM, et al. Fundamental concepts regarding testosterone deficiency and treatment: International Expert Consensus Resolutions. Mayo Clin Proc. 2016. https://pubmed.ncbi.nlm.nih.gov/27313022/
- Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances: 2023 Proposed Rules. https://www.fda.gov/news-events/press-announcements/fda-approves-new-oral-testosterone-capsule-treatment-men-certain-forms-hypogonadism
- Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009. https://pubmed.ncbi.nlm.nih.gov/19333165/
- Nieschlag E, Behre HM, Nieschlag S. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012. https://pubmed.ncbi.nlm.nih.gov/22234464/
- Carroll PH, Jacobson JL. Adult Male Hypogonadism: Diagnosis and Management. Am Fam Physician. 2016;93(12):971-978. https://pubmed.ncbi.nlm.nih.gov/27304510/
- Snyder PJ. Hypogonadism in elderly men. N Engl J Med. 2004. https://pubmed.ncbi.nlm.nih.gov/14762181/